decentralized clinical trials
-
When Flexibility Drives Broader Patient Engagement
Read more: When Flexibility Drives Broader Patient EngagementMakes the case to sponsors that planned flexibility, including remote consent, hybrid visits, and varied communication, widens participation, improves retention and equity,…
-
The Invisible Patients in Clinical Trials
Read more: The Invisible Patients in Clinical TrialsExamines why willing patients never reach trials due to awareness, geographic, and process barriers, and proposes community partnerships, plain-language tools, and hybrid…
-
Overcoming Barriers to Clinical Trial Access
Read more: Overcoming Barriers to Clinical Trial AccessRewritten Aug 2026 and expanded from 681 to 981 words: the site four hours away, or the one line in the rulebook…
-
Tailored Research for Thousands of Rare Conditions
Read more: Tailored Research for Thousands of Rare ConditionsRewritten Aug 2026 for patients: a diagnosis so rare the doctor has to look it up. Explains why rare disease research is…
-
Making Clinical Trials Open to Every Qualified Patient
Read more: Making Clinical Trials Open to Every Qualified PatientMakes the case for accessible, inclusive trial design through decentralized options, financial support, language access, and community partnerships so every qualified patient…
-
Digital Tools Embolden Patients in Clinical Trials
Read more: Digital Tools Embolden Patients in Clinical TrialsDescribes how wearables, telehealth, dashboards, and AI recruitment make trials more accessible and empowering, while cautioning that poorly chosen technology can exclude…